Deliver on your promise! A variety of anti-cancer drugs and medical devices to achieve zero tariffs

The fire started closer to the company gate

A batch of imported anti-cancer drugs and medical devices are about to reduce prices again.

On December 15, the Ministry of Finance of the People's Republic of China issued a document announcing that it will implement zero tariffs on a number of drugs, including radium chloride injection, a new anti-cancer drug, and reduce the import tariffs on some medical devices such as intracranial thrombotic stents and artificial joints, reducing the economic burden on patients.

Source: The official website of the Ministry of Finance of the People's Republic of China

The new tax rate will be implemented from 1 January 2022. The total number of goods subject to the provisional import tax rate below the MFN rate reached 954, many of which were pharmaceuticals and medical devices.

Among them, the implementation of zero tariffs includes a variety of anti-cancer drugs and rare disease drug raw materials, but also includes empagliflozin, bepoprost sodium, entecavir, vifiliptin and other drugs.

Since 2018, the Chinese government has promised to gradually reduce the "import tax rate of anti-cancer drugs to zero tax rate". Since then, under the comprehensive influence of zero tariffs, medical insurance negotiations, collection and other policies, the prices of many imported anti-cancer drugs have dropped sharply.

The reduced tax rate of medical devices includes 11 types of intracranial embolic stents, other respiratory apparatus and gas masks, dental fixtures, artificial joints, artificial heart valves, and hearing aids.

In 2022, some medical devices such as ozone therapy devices, oxygen therapizers, spray therapists, artificial respirators and other therapeutic respiratory appliances have been deleted; invasive ventilators and non-invasive ventilators have been added, with a general tax rate of 17%, and masks have been added, and the ordinary tax rate is 100%.

In addition, the Ministry of Finance has also increased the import and export tariffs on some goods within the scope of China's commitment to join the World Trade Organization, for example, the ordinary tax rate for orthopedic or fractured instruments will increase from 17% to 57% according to the needs of domestic industrial development and changes in supply and demand. After the adjustment, the total level of China's tariffs continued to remain at 7.4%.

Wen | Zhang Ling

Operational | Twenty-thirteen

Two in-depth manuscripts per day to decode medicine and health

#抗癌药品进口税率降到零税率 #